NCT05781568View on ClinicalTrials.gov

Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC)

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

February 24, 2023

Primary Completion Date

June 27, 2024

Study Completion Date

January 27, 2025

Conditions
HCCCirrhosis, LiverNAFLDHBVHCV
Interventions
DIAGNOSTIC_TEST

Biomarker dosage

The simultaneous dosage of the 3 serum biomarkers will be performed at the Clinical Pathology Laboratory, using the instrument: µTASWakoTM i30 (Micro Total Analysis System) - Fujifilm.

Trial Locations (1)

70013

RECRUITING

"RCCS Saverio de Bellis", Castellana Grotte

All Listed Sponsors
collaborator

Dr. Raffaele Cozzolongo

UNKNOWN

collaborator

Dr. Palma Aurelia Iacovazzi

UNKNOWN

collaborator

Dr. Vito Giannuzzi

UNKNOWN

collaborator

Dr. Francesco Losito

UNKNOWN

collaborator

Dr. Marianna Zappimbulso

UNKNOWN

lead

Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

OTHER